Elekta slumps on Q4 order miss, 'vague' guidance
BUZZ-Elekta slumps on Q4 order miss, 'vague' guidance ** Shares in Elekta EKTAb.ST fall as much as 15.9% after the Swedish medical technology group reported a sharp miss in quarterly orders and gave a vague outlook
** J.P. Morgan says Q4 orders came in 21.7% below consensus, reflecting weaker activity in emerging markets, while revenue of SEK 4.76 billion ($512.1 million) also missed expectations
** The broker flags guidance as "relatively vague" and "even less specific than before", with the company pointing only to sales growth and margin improvement without quantifying either
** Elekta says 2026/27 net sales in constant exchange rates will rise year-on-year, alongside an improvement in EBIT margin
** J.P. Morgan says the results reinforce its view that while the new CEO has moved quickly on costs to protect margins, investors are likely to be more concerned on the revenue outlook
** Shares pare losses to 9%, on track for their worst day since June 2024
($1 = 9.2983 Swedish crowns)
(Reporting by Marta Frackowiak)